Trending
Revolutionary Shows Promise 4
Revolutionary Shows Promise 3
Revolutionary Shows Promise 1
Revolutionary aids Treatment Shows Promise
Revolutionary Cancer Treatment Shows Promise
FDA Expands Approval of Vonvendi for von Willebrand Disease, Including Pediatric Use
Child Depression Fluctuations may trigger Parent Depression not vice versa: JAMA
Indoor Air Quality and Diet Found to Regulate Inflammation in Childhood: Study Finds
How Smoking Fuels Pancreatic Cancer Growth and Worsens Outcomes: Study Finds Out
Follow Us:
November 01, 2025

Get In Touch

GSK pulmonary neuroendocrine carcinoma treatment gets Orphan Drug Designation in EU Oncology

GSK pulmonary neuroendocrine carcinoma treatment gets Orphan Drug Designation in EU

  • 31 October 2025
  • 23 hours ago

Dr Reddy's Labs receives positive EMA Committee opinion for proposed biosimilar of Prolia, Xgeva Obstetrics and Gynaecology

Dr Reddy's Labs receives positive EMA Committee opinion for proposed biosimilar of Prolia, Xgeva

  • 23 September 2025
  • 1 month ago

Roche subcutaneous formulation of Lunsumio recommended by CHMP for EU nod for follicular lymphoma Pharma News

Roche subcutaneous formulation of Lunsumio recommended by CHMP for EU nod for follicular lymphoma

  • 21 September 2025
  • 1 month ago

Merck receives positive EU CHMP opinion for Enflonsia for RSV in infants Pharma News

Merck receives positive EU CHMP opinion for Enflonsia for RSV in infants

  • 21 September 2025
  • 1 month ago

JnJ gets positive CHMP opinion of nipocalimab for antibody-positive patients living with generalised myasthenia gravis Pharma News

JnJ gets positive CHMP opinion of nipocalimab for antibody-positive patients living with generalised myasthenia gravis

  • 21 September 2025
  • 1 month ago

Bayer Elinzanetant recommended for nod in EU for moderate to severe vasomotor symptoms Pharma News

Bayer Elinzanetant recommended for nod in EU for moderate to severe vasomotor symptoms

  • 20 September 2025
  • 1 month ago

EMA Committee approves update to Novo Nordisk Rybelsus label to reflect cardiovascular benefits Pharma News

EMA Committee approves update to Novo Nordisk Rybelsus label to reflect cardiovascular benefits

  • 18 September 2025
  • 1 month ago

EMA Recommends Expanded Use Of Remdesivir On Compassionate Grounds Medicine

EMA Recommends Expanded Use Of Remdesivir On Compassionate Grounds

  • 20 July 2025
  • 3 months ago

Recent News

Global review links common viral infections to hig...

  • 01 November, 2025

Lower ketone levels and improved exercise capacity...

  • 01 November, 2025

Citrus Flavonoids effective nutritional adjunct to...

  • 01 November, 2025

Daily kimchi intake linked to reduced BMI and bell...

  • 01 November, 2025

Aggressive Risk Factor Management Reduces AF Recur...

  • 01 November, 2025

Daily Newsletter

Get all the top stories from Blogs to keep track.